Clinicians should recognize that while the preclinical data is encouraging, prescribing tirzepatide for neuroprotection is investigational and not supported by FDA-approved indications
I will say there are a lot of anecdotal reports about initial insomnia and elevated heart rate (presumably lowered HRV) on the forums, and I did experience that when starting tirzepatide and when trying retatrutide, but the insomnia and heart rate issues seemed transient
Evaluation of the total amount of SOD gives an overview of the overall SOD detoxifying capacity of the studied system
Seeing that 40% of the orders were never filled was surprising, and so were the disparities by race and ethnicity and the differences by indication, Goss says
In the hippocampus, BPC 157 strongly elevates Egr1 , Akt1 , Kras , Src , Foxo , Srf , Vegfr2 , Nos3, and Nos1 expression and decreases Nos2 and Nfkb expression
Published in The Lancet